Investor
Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 410 - (OTC: $SKDI)
(CSE: $NLB.C) (OTC: $PHCG)
(CSE: $IMCC.C) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: $CSUI)
Delta, Kelowna, BC, May 7, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2020/cannabis-potcasts/05071SKDI-NLB-PHCG-IMCC-NRTH-AVCN.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural principles.
Cannabis Suisse products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public and private company
announcements.
Sun Kissed
Industries Inc. (OTC: SKDI), an emerging leader in the CBD Food
and Beverage marketplace, subsidiary Products Group Inc, DBA/ Hakuna Supply announced that April online sales far
surpassed the anticipated numbers.
Hakuna's
retail store clientele have increased their orders ahead of the cross country
're-opening', causing a backlog of thousands of CBD Biometric Sensor Storage
Devices along with multiple orders across all product lines.
A
new affiliate marketing program for Hakuna has been developed with an initial
goal of 10-15 on boarded marketers per month. This program rewards marketers
for their efforts in increasing Hakuna's client base. Please visit Hakuna's
website for an application and full program details: https://hakunasupplycbd.com/affiliate-application/
In
2018, content marketing costs were gauged to be 62% of traditional marketing
schemes while simultaneously generating three times the leads of traditional
methods. According to Bigcommerce.com, the US affiliate market will surpass
$6.8 billion this year.
"The
new clean room is facilitating the fulfillment of increased online and
traditional brick-and-mortar store orders. During the past month we have put
the finishing touches on our affiliate market program launching this month. Our
new combined marketing could result in over $750,000 in new sales this
year," commented Hakuna CEO, Ilan Freeman. "Plans for festivals,
typically during the end of summer and early fall seasons, are further
bolstering sales."
"Our
team at Sun Kissed is working closely with Hakuna to increase inventory and the
number of festivals attended this year. We couldn't be happier with the results
coming in for Q1 and Q2 as well as the outlook for the rest of 2020"
concluded Carl Grant, CEO of Sun Kissed.
NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) announced that it has signed a definitive
agreement dated May 5, 2020 with Trellis Holdings Oregon, LLC. to acquire 37.5%
of the issued and outstanding share capital of Trellis Holdings Oregon Op LLC
from David Joshua Bartch and Benjamin Martch by way of a share exchange, as
previously announced on February 6th, 2020.
Trellis
Holdings Oregon, LLC has been successfully operated since 2015 by a group of
cannabis industry veterans and cultivates thousands of pounds of high-quality
cannabis per year, including strains that exceed 30% in THC content, and has 7
figure revenues that continue to grow significantly year over year. Trellis
holds various licenses with the OLCC in the state of Oregon and operates in
both the medical and recreational cannabis markets, maintaining an 11-acre
recreational cultivation property in Southern Oregon and operating a medical
and recreational cannabis dispensary in Portland, Oregon.
"We
announced the LOI to acquire a position in Trellis some time back and have been
working diligently to close the transaction," commented Joshua Bartch, CEO
of NewLeaf Brands. "This transaction is significant in a number of ways
for the company. Not only does Trellis bring a wealth of assets, potential
revenue and key personnel but the crossover between the cannabis space and the
mycology space is immense."
Mr.
Bartch continued, "Through Initiative #34, Oregon is poised to be the
first territory on the planet to not just decriminalize, but actually legalize,
psychedelic mushrooms in some capacity. Given that Trellis operates its
cultivation in Sothern Oregon on an 11-acre property that is already owned,
debt-free, by NewLeaf Brands, the Company has a unique opportunity to share the
land and staff for a potential future mycology cultivation space and
laboratory." He concluded, "With recent donations to the tune of
$1,000,000 towards the Petition from prominent companies such as Dr. Bronner's
Soap, the likelihood of the initiative becoming a reality is beginning to look
truly promising."
According
to the campaign for the initiative, "IP 34 gives those suffering from
depression, anxiety, and anyone that would benefit, a new treatment option by
creating a licensed and supervised psilocybin-assisted therapy system. Rigorous
studies at leading medical research institutions such as Johns Hopkins, UCLA,
and NYU show that psilocybin therapy is uniquely effective in treating depression,
anxiety, and addiction. This promising research has prompted experts in Oregon
to advance IP 34 for the November ballot — IP 34 will create a licensed
psilocybin therapy program so Oregonians have the best therapeutic options
available."
Pure Harvest Cannabis
Group, Inc. (OTC: PHCG),
an emerging cannabis and hemp-CBD holding company, announced the official launch of its wholly
owned subsidiary, Wild Pet Blends, a
CBD-based pet supplement company.
Wild
Pet Blends offers unique full-spectrum hemp extract products that go beyond
what is currently offered in the CBD market for pets. It’s scientifically
curated blends have been designed as multi-dimensional pet supplements and
chews that combine vitality enhancing full spectrum CBD, anti-oxidants,
essential fats, vitamins, and minerals in combination with digestive enzymes
and probiotics for your pet’s overall health and wellness.
Wild
Pet Blends has an aggressive development plan that includes top-tier sales
talent with over 25 years in the pet industry, distribution partnerships, and
expanded product offerings. The
Company’s ability to produce a steady supply of premium Full-Spectrum hemp oil
that is rich in cannabinoids will be a key differentiating factor for our
product line.
“We
continue to diversify our portfolio of holdings in the cannabis space,” stated
Matt Gregarek, CEO, Pure Harvest Cannabis Group. “Our objective is to develop,
identify, and acquire operations in the fastest growing sectors of the already
rapidly growing cannabis industry and to establish durable revenue lines. The
expansion of the CBD pet market is clear and Wild Pet Blends offers a
tremendous catalog of superior products.”
IM Cannabis Corp. (CSE:IMCC), one of the world's pioneering
medical cannabis companies with operations in Israel and across Europe, announced that its German subsidiary,
Adjupharm GmbH, has obtained definitive purchase commitments for 360kg of
medical cannabis over the next twelve months with two distributors in Germany.
Adjupharm is fully licensed for the import, export and distribution of medical
cannabis products in Germany.
Oren
Shuster, Chief Executive Officer of IMC commented, "Over the past year, we have
taken the steps required to enter the German market and scale quickly, backed
by a 10-year track record of successful operations in Israel. Germany is the
third largest medical cannabis market in the world and continues to present a
large opportunity for focused operators like IMC. The commitments obtained
today are a significant achievement in the roll-out of IMC's strategy in Germany
and they are pivotal to growing brand awareness, with a view to increasing our
international penetration as well as preparing to enter other attractive
countries in the EU. IMC is experienced at building productive relationships
within the retail pharmacy channel and have already formed partnerships with
trusted cultivators for product fulfillment. With $193.5 million in revenue and
expected gross margins of 50% secured through binding agreements over the past
two months in Israel and now purchase commitments in Europe's largest market,
we have made meaningful strides towards our long-term success. Our strategy
will continue to unfold in the coming months as we expand our network of
partnerships to maximize the distribution of IMC-branded products in
Germany."
Through
its EU-GMP certified subsidiary, Adjupharm, the Company has entered into two
binding three-to-twelve month sales agreements with two pharmaceutical
distributors in Germany. Each of the distributors has entered into individual
purchase commitments under the respective sales agreements. The total quantity
of medical cannabis under the Purchase Commitments is 360kg, with 340kg
expected to be delivered in 2020.
The
first shipment to distributors in Germany is expected in June 2020. Medical cannabis
sold under these Purchase Commitments will be fulfilled primarily from the
Company's EU-GMP certified supply partner in Europe.
The
Purchase Commitments are the Company's first binding contracts for the sale of
medical cannabis in Germany under the IMC brand. IMC has also previously
announced that Focus Medical Herbs Ltd. has signed six binding sales agreements
for the distribution of IMC-branded medical cannabis products in Israel. Total
consolidated revenue from all binding sales agreements in Israel is expected to
be $193.5 million with an expected gross margin of 50%. A total of 33,075kg of
medical cannabis will be delivered in Israel between Q2 2020 and 2023, and
3,000kg of medical cannabis under the sales agreements is expected to reach pharmacies
in 2020.
48North Cannabis
Corp. (TSXV:NRTH), announced that it has signed a key supply
agreement with Medical Cannabis by Shoppers Drug Mart Inc., a subsidiary of
Shoppers Drug Mart Inc.
Under
the terms of the agreement, 48North will become a supplier of cannabis and
cannabis products through the Shoppers online sales platform. As a result,
48North-branded products and licensed brands will now be available to Medical
Cannabis by Shoppers™ patients across Canada.
To
begin, the Company will be introducing Apothecanna
by 48North, an established U.S cannabis brand focused on natural topical
formulations, made without the use of artificial ingredients, fillers,
parabens, or GMO ingredients. Apothecanna
has been a leading topicals brand in the United States since its founding in
2009.
"Partnering
with trusted brands like Medical Cannabis by Shoppers has been a cornerstone of
48North's growth plan since the beginning. The Company continues to sign
agreements and build meaningful partnerships with a collection of the most
beloved and trusted brands in Canada. Today's news, announced on the heels of
the Company's agreements with Indigo and Pax, continues to build on 48North's
momentum," said Charles Vennat, CEO of 48North.
"48North
can now truly say that its brand and products are available across the country.
We could not be prouder to partner with one of the most respected brands in
Canadian retail, we look forward to bringing our high-quality, consistent and
natural product offerings to medical cannabis patients," continued
Charles.
Successfully
signing a supply agreement with Shoppers is indicative of 48North's renewed
commitment to improving operations, investing in product development, and
supporting high-quality experiences for Canadian consumers.
48North
applauds the hard work that Shoppers has done to ensure that all Canadians have
access to quality products as well as trusted guidance from their specialized
medical cannabis advisors.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced that, through its cultivation
subsidiary Santa Marta Golden Hemp S.A.S., it has received the approval from
the Colombian government for the industrial export of hemp seeds to the US.
The
export, which is expected to be completed in the next two weeks, is the first
ever export of cannabis seeds from Colombia and will be accomplished thanks to
the support and coordination of the Colombian Institute of Agriculture, and the
Ministries of Agriculture and Justice for Colombia.
"For
the Colombian government, under the leadership of the Ministry of Justice and
Law and during the COVID-19 sanitary emergency, this is a very important
achievement for the medical cannabis industry" said Dumar Cardenas Poveda,
Subdirector of Control and Inspection of Narcotic Drugs and Chemical Substances
of the Ministry of Justice and Law.
"This
is a very important achievement because it can mark the way for an escalation
of future exports in this industry. The ICA, considering the framework of
Decree 613 of 2017, has given the technical support and reviewed the necessary
information to materialize this first exportation. We are opening these new
opportunities for this industry, in which there is a significant business
expectation" said Deyanira Barrero León, Director General of the Colombian
Institute of Agriculture.
"The
cannabis industry in Colombia, being a nascent sector, has faced great
challenges of establishing its pathways and standardizing its regulatory
processes. For this reason, in the particular case of this export, the advice
of ICA and the support of the Ministries of Agriculture and Justice have been
pivotal factors in allowing us to harvest in the times demanded by the client
in the United States." said Lucas Nosiglia, President of Avicanna's Latin
American operations.
Mr.
Nosiglia explained that rather than a single company milestone, this is an
achievement for the whole cannabis industry in Colombia as it also adds a novel
and less visited business market opportunity of genetics and seeds to the
global markets. Mr. Nosiglia emphasized
"This
export is the faithful proof that the cannabis sector is in a position to
support the socio-economic revival that the country requires in the midst of
the COVID-19 pandemic. Medical cannabis attracts foreign investment, generates
employment, increases the nation's tax revenues, expands the export matrix and
contributes to the development of rural areas."
Once again, today’s
podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure: CSUI is a paid
monthly featured cannabis company on Investor ideas. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
